Suchergebnisse - "Angiogenesis Inhibitors/pharmacology"

Normalization of Snai1-mediated vessel dysfunction increases drug response in cancer

Autoren: Helene Hoffmann Martin Wartenberg Sandra Vorlova et al.

Quelle: Oncogene

Schlagwörter: 0301 basic medicine, 0303 health sciences, Epithelial-Mesenchymal Transition, Neovascularization, Pathologic, Endothelial Cells, Angiogenesis Inhibitors, Article, Mice, 03 medical and health sciences, Neoplasms, Cell Line, Tumor, 14/19, Angiogenesis Inhibitors/pharmacology [MeSH], Endothelial Cells/pathology [MeSH], Neovascularization, Pathologic/pathology [MeSH], Cell Line, Tumor [MeSH], 631/67/1059/2326, Tumor Microenvironment/drug effects [MeSH], Endothelial Cells/drug effects [MeSH], Neovascularization, Pathologic/metabolism [MeSH], Neoplasms/metabolism [MeSH], 13/51, 631/67/327, 38/109, Neoplasms/pathology [MeSH], Human Umbilical Vein Endothelial Cells [MeSH], 631/67/322, Snail Family Transcription Factors/metabolism [MeSH], 14/63, 13/2, Endothelial Cells/metabolism [MeSH], Female [MeSH], Neoplasms/blood supply [MeSH], 82/80, Epithelial-Mesenchymal Transition/drug effects [MeSH], Humans [MeSH], 631/67/2328, Neoplasms/genetics [MeSH], Animals [MeSH], 64/60, Epithelial-Mesenchymal Transition/genetics [MeSH], Neovascularization, Pathologic/drug therapy [MeSH], Mice [MeSH], Neovascularization, Pathologic/genetics [MeSH], 82, Neoplasms/drug therapy [MeSH], 38/89, 64, article, Snail Family Transcription Factors/genetics [MeSH], Tumor Microenvironment, Human Umbilical Vein Endothelial Cells, Animals, Humans, Female, Snail Family Transcription Factors

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/39095583
https://repository.publisso.de/resource/frl:6503989

2-Desaza-annomontine (C81) impedes angiogenesis through reduced VEGFR2 expression derived from inhibition of CDC2-like kinases

Autoren: T. J. Zech A. Wolf M. Hector et al.

Quelle: Angiogenesis

Schlagwörter: Inflammation, Vascular Endothelial Growth Factor A, 0301 basic medicine, Original Paper, 0303 health sciences, Angiogenesis Inhibitors/pharmacology [MeSH], Endothelial Cells/metabolism [MeSH], beta Catenin/metabolism [MeSH], Kinase inhibitor, CDC-2-like-kinases, Carbolines [MeSH], Humans [MeSH], Inflammation [MeSH], Human Umbilical Vein Endothelial Cells/metabolism [MeSH], Splicing, Animals [MeSH], Angiogenesis [MeSH], Neovascularization, Pathologic/drug therapy [MeSH], WNT-signaling, Wnt Signaling Pathway [MeSH], Mice [MeSH], Vascular Endothelial Growth Factor A/metabolism [MeSH], Natural product, Pyrimidines [MeSH], Angiogenesis, Vascular Endothelial Growth Factor Receptor-2/metabolism [MeSH], Neovascularization, Pathologic, Endothelial Cells, Angiogenesis Inhibitors, Vascular Endothelial Growth Factor Receptor-2, Mice, 03 medical and health sciences, Pyrimidines, Human Umbilical Vein Endothelial Cells, Animals, Humans, Wnt Signaling Pathway, beta Catenin, Carbolines

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/38403816
https://repository.publisso.de/resource/frl:6518611

Comprehensive biomarker and modeling approach to support dose finding for BI 836880, a VEGF/Ang-2 inhibitor

Autoren: Sascha Keller Ulrich Kunz Ulrike Schmid et al.

Quelle: J Transl Med
Journal of Translational Medicine, Vol 22, Iss 1, Pp 1-18 (2024)

Schlagwörter: Vascular Endothelial Growth Factor A, Adult, Male, Ang-2, Dose-Response Relationship, Drug, Research, BI 836880, Angiogenesis Inhibitors, Middle Aged, Angiogenesis Inhibitors/pharmacology [MeSH], Vascular Endothelial Growth Factor A/blood [MeSH], Biomarkers, Aged [MeSH], Models, Biological [MeSH], Male [MeSH], VEGF, Dose-Response Relationship, Drug [MeSH], Female [MeSH], Angiopoietin-2/blood [MeSH], Adult [MeSH], Angiogenesis Inhibitors/administration, Biomarkers/blood [MeSH], Humans [MeSH], Middle Aged [MeSH], Pharmacodynamics, Angiopoietin-2/antagonists, Disease Biomarkers, Biomarkers, Tumor/blood [MeSH], Neoplasms/drug therapy [MeSH], Pharmacokinetics, Angiogenesis Inhibitors/therapeutic use [MeSH], Models, Biological, Angiopoietin-2, Neoplasms, Biomarkers, Tumor, Medicine, Humans, Female, Aged

Dateibeschreibung: pdf

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/39402675
https://doaj.org/article/e16d3e8186014e00ab772fd03b57d4cc
https://repository.publisso.de/resource/frl:6518615

Platycodin D Inhibits Vascular Endothelial Growth Factor-Induced Angiogenesis by Blocking the Activation of Mitogen-Activated Protein Kinases and the Production of Interleukin-8

Autoren: Ju-Ah, Son Sun Kyoung, Lee Junhee, Park et al.

Weitere Verfasser: Ju-Ah, Son Sun Kyoung, Lee Junhee, Park et al.

Quelle: The American Journal of Chinese Medicine. 50:1645-1661

Schlagwörter: Vascular Endothelial Growth Factor A, 0301 basic medicine, Human Umbilical Vein Endothelial Cells / metabolism, Vascular Endothelial Growth Factor A* / metabolism, Angiogenesis Inhibitors, Interleukin-8* / metabolism, Mice, 03 medical and health sciences, Pathologic / drug therapy, Vascular Endothelial Growth Factors / pharmacology, MAPKs, Cell Movement, Human Umbilical Vein Endothelial Cells, Animals, Humans, Extracellular Signal-Regulated MAP Kinases, Neovascularization, Neovascularization, Pathologic, Vascular Endothelial Growth Factors, Interleukin-8, Vascular Endothelial Growth Factors / metabolism, Saponins, Pathologic / prevention & control, VEGF, Triterpenes, 3. Good health, Tumor Angiogenesis, Angiogenesis Inhibitors / pharmacology, Extracellular Signal-Regulated MAP Kinases / metabolism, Platycodin D

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/35848124

Novel Small Molecules with Anti-Inflammatory and Anti-Angiogenic Activity in a Mouse Model of Oxygen-Induced Retinopathy

Autoren: Dayoub, Adam S. Acharya, Eesha Dibas, Adnan et al.

Quelle: Cells

Schlagwörter: TLR2, TLR4, anti-angiogenic, anti-inflammatory, cytotoxic immune cells, prevention, retinopathy of prematurity, treatment, Disease Models, Animal, Oxygen / metabolism, Retinopathy of Prematurity / pathology, Retinopathy of Prematurity / drug therapy, Retinopathy of Prematurity / metabolism, Angiogenesis Inhibitors / pharmacology, Angiogenesis Inhibitors / therapeutic use, Anti-Inflammatory Agents / pharmacology

Dateibeschreibung: application/pdf

Relation: https://doi.org/10.3390/cells13161371; https://hdl.handle.net/20.500.12503/32907; 13; 16

Verfügbarkeit: https://hdl.handle.net/20.500.12503/32907

Development of Novel VEGFR2 Inhibitors Originating from Natural Product Analogues with Antiangiogenic Impact

Autoren: Ho Jeong Kwon György Marko-Varga Sung Min Cho et al.

Weitere Verfasser: Ho Jeong Kwon György Marko-Varga Sung Min Cho et al.

Quelle: Journal of Medicinal Chemistry. 64:15858-15867

Schlagwörter: 0301 basic medicine, Biological Products / pharmacology, Nude, Antineoplastic Agents / pharmacology, Xenograft Model Antitumor Assaysz, Mice, Nude, Angiogenesis Inhibitors, Antineoplastic Agents, Biological Products / chemistry, Cell Line, Mice, Structure-Activity Relationship, 03 medical and health sciences, Vascular Endothelial Growth Factor Receptor-2 / antagonists & inhibitors, Drug Development, Cell Line, Tumor, Vascular Endothelial Growth Factor Receptor-2 / metabolism, Human Umbilical Vein Endothelial Cells, Animals, Humans, Phosphorylation, Biological Products, 0303 health sciences, Tumor, Cell Death, Angiogenesis Inhibitors / pharmacology, Vascular Endothelial Growth Factor Receptor-2, Xenograft Model Antitumor Assays, Angiogenesis Inhibitors / chemistry, Cell Death / drug effects

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/34730352
https://europepmc.org/article/MED/34730352
https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.1c01168

Pro-inflammatory activation changes intracellular transport of bevacizumab in the retinal pigment epithelium in vitro

Autoren: Julia Hildebrandt Tom Käckenmeister Katrin Winkelmann et al.

Quelle: Graefes Arch Clin Exp Ophthalmol

Schlagwörter: Bevacizumab, 0301 basic medicine, 03 medical and health sciences, 0302 clinical medicine, Basic Science, Swine, Blotting, Western, Angiogenesis Inhibitors/pharmacology [MeSH], Swine [MeSH], Actin filaments, Myosin 7a, Animals [MeSH], Retinal pigment epithelium (RPE), Transepithelial transport, Retinal Pigment Epithelium/metabolism [MeSH], Bevacizumab/pharmacology [MeSH], Toll-like receptor (TLR-3), Cells, Cultured [MeSH], Blotting, Western [MeSH], Animals, Angiogenesis Inhibitors, Retinal Pigment Epithelium, Cells, Cultured, 3. Good health

Zugangs-URL: https://link.springer.com/content/pdf/10.1007/s00417-021-05443-2.pdf
https://pubmed.ncbi.nlm.nih.gov/34643794
https://link.springer.com/article/10.1007/s00417-021-05443-2
https://link.springer.com/content/pdf/10.1007/s00417-021-05443-2.pdf
https://repository.publisso.de/resource/frl:6450110

B55α/PP2A Limits Endothelial Cell Apoptosis During Vascular Remodeling: A Complementary Approach To Disrupt Pathological Vessels?

Autoren: Elizabeth A. V. Jones Donatella Ponti Massimiliano Mazzone et al.

Quelle: Articles publicats en revistes (IDIBAPS: Institut d'investigacions Biomèdiques August Pi i Sunyer)
Dipòsit Digital de la UB
instname

Schlagwörter: Male, 0301 basic medicine, Cardiac & Cardiovascular Systems, p38 Mitogen-Activated Protein Kinases/metabolism, Oncologia, B55/PP2A-phosphatase, tumor progression, Angiogenesis Inhibitors, Apoptosis, Human Umbilical Vein Endothelial Cells/drug effects, Inbred C57BL, p38 Mitogen-Activated Protein Kinases, ANGIOGENESIS, ACTIVATION, Mice, Carcinoma, Lewis Lung, Protein Phosphatase 2/antagonists & inhibitors, Protein Phosphatase 2, Enzyme Inhibitors, Phosphorylation, 1102 Cardiorespiratory Medicine and Haematology, Endothelial Cells/drug effects, Enzyme Inhibitors/pharmacology, Mice, Knockout, Hypoxia-Inducible Factor-Proline Dioxygenases/genetics, 0303 health sciences, Tumor, vascular endothelial growth factor, Neovascularization, Pathologic, apoptosis, P38, PROTEIN PHOSPHATASE 2A, Hematology, VEGF, endothelial cells, PP2A, 3. Good health, Oncology, oncology, Female, Biologia del desenvolupament, 3201 Cardiovascular medicine and haematology, Life Sciences & Biomedicine, Signal Transduction, Lewis Lung/drug therapy, Knockout, INHIBITION, Breast Neoplasms, Vascular Remodeling, perfusion, Cell Line, MECHANISMS, Hypoxia-Inducible Factor-Proline Dioxygenases, Angiogenesis Inhibitors/pharmacology, blood vessels, developmental biology, 03 medical and health sciences, Breast Neoplasms/drug therapy, Cell Line, Tumor, Developmental biology, KINASE, Human Umbilical Vein Endothelial Cells, Animals, Humans, Neovascularization, Pathologic, Science & Technology, Carcinoma, 3202 Clinical sciences, Endothelial Cells, 1103 Clinical Sciences, Mice, Inbred C57BL, Peripheral Vascular Disease, Cardiovascular System & Hematology, METASTASIS, Cardiovascular System & Cardiology

Dateibeschreibung: application/pdf

Zugangs-URL: https://www.ahajournals.org/doi/pdf/10.1161/CIRCRESAHA.119.316071
https://pubmed.ncbi.nlm.nih.gov/32527198
https://hdl.handle.net/2445/199448
https://cris.maastrichtuniversity.nl/en/publications/d96637ad-1fdd-4778-a8d9-ff88a0197f22
https://doi.org/10.1161/CIRCRESAHA.119.316071
https://pubmed.ncbi.nlm.nih.gov/32527198/
https://iris.unito.it/handle/2318/1782133
https://www.ahajournals.org/doi/10.1161/CIRCRESAHA.119.316071
https://www.ncbi.nlm.nih.gov/pubmed/32527198
https://www.narcis.nl/publication/RecordID/oai%3Acris.maastrichtuniversity.nl%3Apublications%2Fd96637ad-1fdd-4778-a8d9-ff88a0197f22
https://www.scilit.net/article/90dc76a9603b09c6a249ba2b51c4ae9b
http://hdl.handle.net/2445/199448
https://hdl.handle.net/2318/1782133
https://doi.org/10.1161/CIRCRESAHA.119.316071

Aflibercept regulates retinal inflammation elicited by high glucose via the PlGF/ERK pathway.

Autoren: Lazzara, F. Fidilio, A. Platania, CBM et al.

Schlagwörter: Angiogenesis Inhibitors/pharmacology, Animals, Cells, Cultured, Computer Simulation, Endothelial Cells/drug effects, Extracellular Signal-Regulated MAP Kinases/genetics, Extracellular Signal-Regulated MAP Kinases/metabolism, Glucose/toxicity, Humans, Inflammation/drug therapy, Membrane Proteins/metabolism, Mice, Models, Biological, Molecular, Protein Binding, Protein Conformation, Protein Domains, Rats, Receptors, Vascular Endothelial Growth Factor, Recombinant Fusion Proteins/pharmacology, Retina/cytology, Retinal Diseases/drug therapy, Aflibercept, Diabetic retinopathy, PlGF, TNF-α, VEGF

Relation: Biochemical Pharmacology; https://iris.unil.ch/handle/iris/80727; serval:BIB_0A79566833B0; 000506423900042

Verfügbarkeit: https://iris.unil.ch/handle/iris/80727
https://doi.org/10.1016/j.bcp.2019.07.021

Le renouveau du thalidomide. Un vieux medicament aux nouvelles indications. [The revival of thalidomide: an old drug with new indications]

Autoren: Laffitte, E.

Schlagwörter: Angiogenesis Inhibitors/pharmacology/*therapeutic use Drug Eruptions Humans Leprostatic Agents/pharmacology/*therapeutic use Peripheral Nervous System Diseases/chemically induced Skin Diseases/drug therapy Teratogens/pharmacology Thalidomide/pharmacology/*therapeutic use Thrombosis/chemically induced

Relation: Revue du praticien; https://iris.unil.ch/handle/iris/59949; serval:BIB_313578B2381C

Verfügbarkeit: https://iris.unil.ch/handle/iris/59949

Targeting vascular NADPH oxidase 1 blocks tumor angiogenesis through a PPARα mediated mechanism.

Autoren: Garrido-Urbani, S. Jemelin, S. Deffert, C. et al.

Schlagwörter: Angiogenesis Inhibitors/pharmacology, Angiogenesis Inhibitors/therapeutic use, Animals, Cells, Cultured, Endothelial Cells/drug effects, Endothelial Cells/metabolism, Female, Gene Knockdown Techniques, Gene Targeting, Humans, Mice, Inbred C57BL, Knockout, Models, Biological, Molecular Targeted Therapy, NADH, NADPH Oxidoreductases/antagonists & inhibitors, NADPH Oxidoreductases/genetics, Neoplasms/blood supply, Neoplasms/drug therapy, Neovascularization, Pathologic/drug therapy, Pathologic/genetics, PPAR alpha/genetics, PPAR alpha/physiology, Pyrazoles/pharmacology, Pyrazoles/therapeutic use, Pyridones/pharmacology

Dateibeschreibung: application/pdf

Relation: PLoS ONE; https://iris.unil.ch/handle/iris/257740; serval:BIB_E36D61042E0B; 000287037100005

Verfügbarkeit: https://iris.unil.ch/handle/iris/257740
https://doi.org/10.1371/journal.pone.0014665

Impact of smoking status on the relative efficacy of the EGFR TKI/angiogenesis inhibitor combination therapy in advanced NSCLC-a systematic review and meta-analysis.

Autoren: Dafni, U. Soo, R.A. Peters, S. et al.

Schlagwörter: Angiogenesis Inhibitors/pharmacology, Angiogenesis Inhibitors/therapeutic use, Antineoplastic Agents/therapeutic use, Carcinoma, Non-Small-Cell Lung/drug therapy, ErbB Receptors, Humans, Lung Neoplasms/drug therapy, Protein Kinase Inhibitors/pharmacology, Protein Kinase Inhibitors/therapeutic use, Smoking/adverse effects, Smoking/epidemiology, EGFR mutations, EGFR-TKI, NSCLC, randomised controlled trial, smoking status

Dateibeschreibung: application/pdf

Relation: ESMO Open; https://iris.unil.ch/handle/iris/247023; serval:BIB_EABD7EDC5C76; 000886288700005

Verfügbarkeit: https://iris.unil.ch/handle/iris/247023
https://doi.org/10.1016/j.esmoop.2022.100507

Pharmacological inhibition of poly(ADP-ribose) polymerase inhibits angiogenesis

Autoren: Rajesh, M. Mukhopadhyay, P. Batkai, S. et al.

Schlagwörter: Angiogenesis Inhibitors/*pharmacology Benzamides/pharmacology Cell Movement/drug effects Cell Proliferation/drug effects Cell Survival/drug effects Cells, Cultured Endothelium, Vascular/cytology/drug effects/growth & development Enzyme Inhibitors/pharmacology Humans Phenanthrenes/pharmacology Poly(ADP-ribose) Polymerases/*antagonists & inhibitors Vascular Endothelial Growth Factor A/antagonists & inhibitors

Dateibeschreibung: application/pdf

Relation: Biochemical and Biophysical Research Communications; https://iris.unil.ch/handle/iris/194115; serval:BIB_7540CFBF4523; 000241389900015

Verfügbarkeit: https://iris.unil.ch/handle/iris/194115
https://doi.org/10.1016/j.bbrc.2006.09.049

Zoledronate sensitizes endothelial cells to tumor necrosis factor-induced programmed cell death: evidence for the suppression of sustained activation of focal adhesion kinase and protein kinase B/Akt.

Autoren: Bezzi, M. Hasmim, M. Bieler, G. et al.

Schlagwörter: Adenoviridae/genetics, Angiogenesis Inhibitors/pharmacology, Annexin A5/metabolism, Apoptosis, Cell Adhesion/drug effects, Cell Death, Cell Membrane/metabolism, Cell Movement/drug effects, Cell Survival/drug effects, Cells, Cultured, Clodronic Acid/pharmacology, Coloring Agents/pharmacology, Diphosphonates/pharmacology, Electroporation, Endothelial Cells/drug effects, Endothelial Cells/pathology, Endothelium, Vascular/cytology, Enzyme Activation, Flow Cytometry, Focal Adhesion Kinase 1, Focal Adhesion Protein-Tyrosine Kinases, Humans, Imidazoles/pharmacology, Integrin alpha5beta1/metabolism, Integrin alphaVbeta3/metabolism, Microscopy, Fluorescence, Phosphorylation

Relation: Journal of Biological Chemistry; https://iris.unil.ch/handle/iris/150705; serval:BIB_876BE72DFD51; 000186157000108

Verfügbarkeit: https://iris.unil.ch/handle/iris/150705
https://doi.org/10.1074/jbc.M308114200

Angiogenesis and Anti-Angiogenic Treatment in Prostate Cancer: Mechanisms of Action and Molecular Targets.

Autoren: Ioannidou, E. Moschetta, M. Shah, S. et al.

Schlagwörter: Angiogenesis Inhibitors/pharmacology, Angiogenesis Inhibitors/therapeutic use, Animals, Antineoplastic Agents/pharmacology, Antineoplastic Agents/therapeutic use, Drug Resistance, Neoplasm, Humans, Male, Molecular Targeted Therapy, Neovascularization, Pathologic/drug therapy, Prostatic Neoplasms/blood supply, Prostatic Neoplasms/drug therapy, advances, antiangiogenics, castration-resistant prostate cancer, hormone-sensitive prostate cancer, prostate cancer

Dateibeschreibung: application/pdf

Relation: International Journal of Molecular Sciences; https://iris.unil.ch/handle/iris/128639; serval:BIB_3CFEA4E724AA; 000699688500001

Verfügbarkeit: https://iris.unil.ch/handle/iris/128639
https://doi.org/10.3390/ijms22189926

Extracellular vimentin mimics VEGF and is a target for anti-angiogenic immunotherapy

Autoren: van Beijnum, Judy R. Huijbers, Elisabeth J. M. van Loon, Karlijn et al.

Quelle: Nat Commun
Nature Communications, Vol 13, Iss 1, Pp 1-20 (2022)
van Beijnum, J R, Huijbers, E J M, van Loon, K, Blanas, A, Akbari, P, Roos, A, Wong, T J, Denisov, S S, Hackeng, T M, Jimenez, C R, Nowak-Sliwinska, P & Griffioen, A W 2022, 'Extracellular vimentin mimics VEGF and is a target for anti-angiogenic immunotherapy', Nature Communications, vol. 13, no. 1, 2842. https://doi.org/10.1038/s41467-022-30063-7
Nature Communications

Schlagwörter: Vascular Endothelial Growth Factor A, 0301 basic medicine, Intermediate Filaments/metabolism, Science, Intermediate Filaments, Cancer immunotherapy, Angiogenesis Inhibitors, Endothelial Cells/metabolism, Vascular Endothelial Growth Factor A/pharmacology, INFILTRATING DENDRITIC CELLS, Article, MECHANISMS, TUMOR ANGIOGENESIS, Angiogenesis Inhibitors/pharmacology, ACTIVATION, 03 medical and health sciences, Pathologic/metabolism, Neoplasms, Humans, Vimentin, Neovascularization, GENE-EXPRESSION, INTERMEDIATE-FILAMENTS, 0303 health sciences, UNCONVENTIONAL SECRETION, Neovascularization, Pathologic, Endothelial Cells, CANCER, ENDOTHELIAL-CELLS, 3. Good health, Tumour immunology, VACCINATION, Immunotherapy, Tumour angiogenesis, Neoplasms/metabolism

Dateibeschreibung: application/pdf

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/35606362
https://doaj.org/article/940243d65bf0461c97115d8cd768c41f
https://research.vumc.nl/en/publications/3bfc8dc3-5923-4dc6-aff6-d9ed6f08bf64

Proteome Analysis of Aflibercept Intervention in Experimental Central Retinal Vein Occlusion

Autoren: Cehofski, Lasse Jørgensen Kruse, Anders Alsing, Alexander Nørgaard et al.

Quelle: Cehofski, L J, Kruse, A, Alsing, A N, Sejergaard, B F, Nielsen, J E, Schlosser, A, Sorensen, G L, Grauslund, J, Honoré, B & Vorum, H 2022, 'Proteome Analysis of Aflibercept Intervention in Experimental Central Retinal Vein Occlusion', Molecules, vol. 27, no. 11, 3360. https://doi.org/10.3390/molecules27113360

Schlagwörter: Angiogenesis Inhibitors/pharmacology, Animals, Intravitreal Injections, Macular Edema/complications, Proteome, Proteomics, Receptors, Vascular Endothelial Growth Factor, Recombinant Fusion Proteins/pharmacology, Retinal Vein Occlusion/complications, Swine, Vascular Endothelial Growth Factor A, Visual Acuity, aflibercept, retinal vein occlusion, retina, mass spectrometry

Dateibeschreibung: application/pdf

Relation: info:eu-repo/semantics/altIdentifier/pmid/35684299; info:eu-repo/semantics/altIdentifier/pissn/1420-3049; info:eu-repo/semantics/altIdentifier/eissn/1431-5157

Verfügbarkeit: https://vbn.aau.dk/da/publications/a0511a5e-7b35-42df-9c09-c8f74152a497
https://doi.org/10.3390/molecules27113360
https://vbn.aau.dk/ws/files/474599778/Cehofski_et_al._2022_._Proteome_Analysis_of_Aflibercept_Intervention_in_Experimental_Central_Retinal_Vein_Occlusion.pdf
https://www.scopus.com/pages/publications/85130525319

A Bivalent Role of Genistein in Sprouting Angiogenesis

Autoren: Berndt, Sarah Issa, Mark Elia Carpentier, Gilles et al.

Weitere Verfasser: Berndt, Sarah Issa, Mark Elia Carpentier, Gilles et al.

Quelle: Planta Medica, Vol. 84, No 9-10 (2018) pp. 653-661

Schlagwörter: Physiologic/drug effects, 0301 basic medicine, ddc:615, 0303 health sciences, Genistein/pharmacology, Neovascularization, Physiologic, Angiogenesis Inhibitors, Genistein, Angiogenesis Inducing Agents/pharmacology, 3. Good health, Angiogenesis Inhibitors/pharmacology, [SDV] Life Sciences [q-bio], 03 medical and health sciences, Human Umbilical Vein Endothelial Cells, Humans, Angiogenesis Inducing Agents, Neovascularization

Dateibeschreibung: application/pdf

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/29539645
https://europepmc.org/article/MED/29539645
https://www.thieme-connect.de/products/ejournals/pdf/10.1055/a-0587-5991.pdf
https://www.thieme-connect.com/products/ejournals/abstract/10.1055/a-0587-5991
https://archive-ouverte.unige.ch/unige:121507
https://www.ncbi.nlm.nih.gov/pubmed/29539645
https://www.thieme-connect.com/products/ejournals/pdf/10.1055/a-0587-5991.pdf
https://archive-ouverte.unige.ch/unige:121507

PD-L1 tumour expression is predictive of pazopanib response in soft tissue sarcoma

Weitere Verfasser: Sang Kyum Kim Jee Hung Kim Seung Hyun Kim et al.

Schlagwörter: Adult, Aged, Angiogenesis Inhibitors / pharmacology, Angiogenesis Inhibitors / therapeutic use, B7-H1 Antigen / metabolism, Female, Humans, Male, Middle Aged, Prognosis, Pyrimidines / pharmacology, Pyrimidines / therapeutic use, Retrospective Studies, Sarcoma / drug therapy, Sulfonamides / pharmacology, Sulfonamides / therapeutic use, Biomarker, PD-L1, Pazopanib, Soft tissue sarcoma

Relation: BMC CANCER; J00351; https://ir.ymlib.yonsei.ac.kr/handle/22282913/184431; T202103008

Verfügbarkeit: https://ir.ymlib.yonsei.ac.kr/handle/22282913/184431
https://doi.org/10.1186/s12885-021-08069-z

The effect of indatraline on angiogenesis suppression through HIF-1α-mediated VEGF inhibition

Autoren: Chih-na Yen Yoon Sun Cho Ho Jeong Kwon et al.

Weitere Verfasser: Chih-na Yen Yoon Sun Cho Ho Jeong Kwon et al.

Quelle: Biochemical and Biophysical Research Communications. 485:349-354

Schlagwörter: 0301 basic medicine, Methylamines / chemistry, Angiogenesis Inhibitors, Chick Embryo, Chorioallantoic Membrane, Pathologic / metabolism, Cells, Cultured, Indans / chemistry, 0303 health sciences, Cultured, Molecular Structure, Neovascularization, Pathologic, Pathologic / prevention & control, Cell Hypoxia, 3. Good health, Anticancer, Vascular Endothelial Growth Factor A / metabolism, Indans, mTOR, Hypoxia-Inducible Factor 1, Drug, Chorioallantoic Membrane / drug effects, Human Umbilical Vein Endothelial Cells / physiology, Angiogenesis Inhibitors / chemistry, Cells, Immunoblotting, HIF-1α, Neovascularization, Physiologic, Enzyme-Linked Immunosorbent Assay, Dose-Response Relationship, Indans / pharmacology, Human Umbilical Vein Endothelial Cells / drug effects, alpha Subunit / metabolism, Methylamines, 03 medical and health sciences, Autophagy / drug effects, Autophagy, Human Umbilical Vein Endothelial Cells, Animals, Humans, Neovascularization, Cell Proliferation, Dose-Response Relationship, Drug, Physiologic / drug effects, Hypoxia-Inducible Factor 1, alpha Subunit, Methylamines / pharmacology, Cell Proliferation / drug effects, Chorioallantoic Membrane / blood supply, Angiogenesis, Angiogenesis Inhibitors / pharmacology, HeLa Cells

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/28216154
https://pubmed.ncbi.nlm.nih.gov/28216154/
https://yonsei.pure.elsevier.com/en/publications/the-effect-of-indatraline-on-angiogenesis-suppression-through-hif
https://www.sciencedirect.com/science/article/pii/S0006291X17303583
https://www.ncbi.nlm.nih.gov/pubmed/28216154